Trial intelligence / Profile preview

Effect of anxiety on ciprofol dose–response for preventing movement during cervical dilation

ChiCTR2500108366Phase 4Recruiting

Sponsor
Shaoxing University Affiliated Hospital
Start
Aug 2025
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in anxiety disorder and Gynecologic procedural pain (2 arms), sponsored by Shaoxing University Affiliated Hospital. Primary endpoints: ED90 of ciprofol (with alfentanil) for inhibiting body movement during cervical dilation and Anxiety scores. Started Aug 2025; status: recruiting.

02

Drugs

ciprofol
03

Conditions

anxiety disorderGynecologic procedural pain

Beyond the preview

Go deeper on ChiCTR2500108366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500108366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call